Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Nuo Therapeutics (AURX) is now available.
Nuo Therapeutics, Inc. has announced a delay in filing its Annual Report on Form 10-K, initially expected by April 16, 2024. The postponement is due to the additional time needed for the independent auditors to complete their review of the audited financial statements for 2023. The company anticipates that the report will be filed by April 19, 2024.
For detailed information about AURX stock, go to TipRanks’ Stock Analysis page.
